KA-Pharma SRL
KA-Pharma reported total assets of 164,964 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jun 2026).
The score of KA-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
KA-Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jun 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
KA-Pharma's financial analysis
- Solvency95.5%sector median: 54.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of KA-Pharma
KA-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1005.869.016
- VAT number
- BE1005869016
- Peppol
- Registered · 0208:1005869016 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Feb 2024
- Registered office
- 1080 Molenbeek-Saint-Jean
- Latest accounts
- 2025 · filed on 16 Jun 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
KA-Pharma (SRL) has been based in Molenbeek-Saint-Jean since 2024, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 48,527 € and equity of 157,474 €; its revenue is not published. Its solvency stands at 95.5%, above the median of its sector (54.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to KA-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Walgraeve & Co Other business support service activities n.e.c. Pajottegem · balance sheet 162,823 €
- Bishop Consulting Other business support service activities n.e.c. Ixelles · balance sheet 165,042 €
- De Zorgspruytjes Other business support service activities n.e.c. Brecht · balance sheet 159,172 €
- XINE Other business support service activities n.e.c. Oud-Heverlee · balance sheet 165,139 €
- Waren Other business support service activities n.e.c. Ghent · balance sheet 165,309 €
- IDA Other business support service activities n.e.c. Lokeren · balance sheet 164,532 €
- Pyrsos Other business support service activities n.e.c. Watermael-Boitsfort · balance sheet 164,446 €
- Piramide Other business support service activities n.e.c. Antwerp · balance sheet 164,418 €
Frequently asked questions about KA-Pharma
What is the revenue of KA-Pharma?
KA-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of KA-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1005869016 for KA-Pharma, if the company is VAT-registered. Its company number (CBE) is 1005.869.016.
Where is the registered office of KA-Pharma?
According to the CBE register, the registered office of KA-Pharma is in 1080 Molenbeek-Saint-Jean.
What is the equity of KA-Pharma?
At the close of the 2025 financial year, the equity of KA-Pharma amounts to 157,474 €, a solvency of 95.5% of total assets.
Who manages KA-Pharma?
The register lists 1 active mandates at KA-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of KA-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →